Associated Papers
Genetic and clinical factors associated with the metabolism of valproic acid in post-neurosurgery patients.
Cai X et al.
Progress in Neuro-psychopharmacology & Biological Psychiatry, 2025
Effects of UDP-glucuronosyltransferase (UGT) polymorphisms on the pharmacokinetics of febuxostat in healthy Chinese volunteers.
Lin M et al.
Drug Metabolism and Pharmacokinetics, 2017
Polymorphisms of estrogen metabolism-related genes ESR1, UGT2B17, and UGT1A1 are not associated with osteoporosis in surgically menopausal Japanese women.
Yokota M et al.
Przeglad Menopauzalny = Menopause Review, 2015
An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.
Swart M et al.
Frontiers in Genetics, 2015
26779253 (PubMed )
Supplement: Table1.docx
Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.
Ramírez J et al.
Future Oncology (london, England), 2010
Stereoselective metabolism of racemic carvedilol by UGT1A1 and UGT2B7, and effects of mutation of these enzymes on glucuronidation activity.
Takekuma Y et al.
Biological & Pharmaceutical Bulletin, 2007
Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer.
Nagar S et al.
Oncogene, 2006
Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects.
Saito K et al.
Clinical Biochemistry, 2006
Select a paper to view details